• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Pragmatic Free Trial Meta

Pragmatic Free Trial Meta is a free and non-commercial open data platform and infrastructure that facilitates research on pragmatic trials. It is a platform that collects and shares clean trial data and ratings using PRECIS-2, which allows for multiple and varied meta-epidemiological research studies to compare treatment effects estimates across trials that employ different levels of pragmatism, as well as other design features.

Background

Pragmatic studies provide real-world evidence that can be used to make clinical decisions. However, the use of the term "pragmatic" is not consistent and its definition and assessment requires clarification. Pragmatic trials should be designed to inform clinical practice and policy decisions, rather than to prove a physiological or clinical hypothesis. A pragmatic study should strive to be as close as possible to the real-world clinical practice which include the recruiting participants, setting up, delivery and execution of interventions, determining and analysis outcomes, and primary analysis. This is a major difference from explanatory trials (as described by Schwartz and Lellouch1) which are designed to provide more complete confirmation of a hypothesis.

Studies that are truly pragmatic must not attempt to blind participants or healthcare professionals in order to result in bias in the estimation of the effect of treatment. The trials that are pragmatic should also try to recruit patients from a variety of health care settings to ensure that the results are generalizable to the real world.

Furthermore the focus of pragmatic trials should be on outcomes that are vital to patients, such as quality of life or functional recovery. This is particularly relevant for trials that involve the use of invasive procedures or could have harmful adverse impacts. The CRASH trial29, for example, focused on functional outcomes to evaluate a two-page case report with an electronic system for monitoring of patients in hospitals suffering from chronic heart failure. Similarly, the catheter trial28 used symptomatic catheter-associated urinary tract infections as the primary outcome.

In addition to these features pragmatic trials should reduce the requirements for data collection and trial procedures to reduce costs and time commitments. Finally pragmatic trials should strive to make their results as relevant to actual clinical practice as they can by ensuring that their primary analysis is based on the intention-to-treat method (as described in CONSORT extensions for pragmatic trials).

Many RCTs that don't meet the criteria for pragmatism but have features that are in opposition to pragmatism, have been published in journals of various types and incorrectly labeled as pragmatic. This could lead to misleading claims of pragmaticity, and the usage of the term should be standardized. The creation of the PRECIS-2 tool, which provides an objective and standard assessment of pragmatic characteristics is a great first step.

Methods

In a pragmatic research study it is the intention to inform policy or 프라그마틱 슬롯 팁 슬롯체험 (https://mybookmark.stream) clinical decisions by showing how an intervention could be integrated into routine treatment in real-world contexts. This is different from explanatory trials that test hypotheses regarding the cause-effect connection in idealized settings. In this way, pragmatic trials could have lower internal validity than studies that explain and be more susceptible to biases in their design as well as analysis and conduct. Despite their limitations, pragmatic studies can be a valuable source of information for decision-making within the healthcare context.

The PRECIS-2 tool measures the degree of pragmatism within an RCT by scoring it across 9 domains, ranging from 1 (very explanatory) to 5 (very pragmatic). In this study, the domains of recruitment, organisation and flexibility in delivery, flexible adherence, and follow-up were awarded high scores. However, the principal outcome and the method for missing data was scored below the pragmatic limit. This suggests that a trial can be designed with effective practical features, but without harming the quality of the trial.

It is difficult to determine the amount of pragmatism within a specific trial because pragmatism does not have a binary attribute. Certain aspects of a research study can be more pragmatic than other. Moreover, protocol or logistic modifications during the course of an experiment can alter its pragmatism score. Additionally 36% of the 89 pragmatic trials identified by Koppenaal et al were placebo-controlled or conducted before licensing and most were single-center. Thus, they are not as common and are only pragmatic if their sponsors are tolerant of the lack of blinding in such trials.

A common aspect of pragmatic studies is that researchers attempt to make their findings more meaningful by analyzing subgroups of the trial sample. This can lead to unbalanced comparisons and lower statistical power, increasing the risk of either not detecting or misinterpreting the results of the primary outcome. This was a problem during the meta-analysis of pragmatic trials because secondary outcomes were not corrected for covariates' differences at the baseline.

In addition the pragmatic trials may have challenges with respect to the collection and interpretation of safety data. This is due to the fact that adverse events tend to be self-reported, and are prone to delays, inaccuracies or coding variations. Therefore, it is crucial to improve the quality of outcome ascertainment in these trials, in particular by using national registries rather than relying on participants to report adverse events on the trial's own database.

Results

Although the definition of pragmatism may not mean that trials must be 100% pragmatic, there are benefits to incorporating pragmatic components into clinical trials. These include:

Increased sensitivity to real-world issues which reduces study size and cost and allowing the study results to be faster transferred into real-world clinical practice (by including patients who are routinely treated). However, pragmatic trials can also have disadvantages. The right kind of heterogeneity for instance could allow a study to expand its findings to different settings or patients. However, the wrong type can decrease the sensitivity of the test, and therefore lessen the power of a trial to detect minor treatment effects.

A variety of studies have attempted to categorize pragmatic trials using various definitions and scoring methods. Schwartz and Lellouch1 created a framework to distinguish between explanatory studies that confirm a physiological hypothesis or clinical hypothesis and pragmatic studies that help inform the selection of appropriate therapies in the real-world clinical practice. The framework was composed of nine domains scored on a 1-5 scale, with 1 being more informative and 5 was more pragmatic. The domains were recruitment, setting, intervention delivery with flexibility, follow-up and primary analysis.

The original PRECIS tool3 featured similar domains and a scale of 1 to 5. Koppenaal et al10 devised an adaptation to this assessment dubbed the Pragmascope which was more user-friendly to use in systematic reviews. They found that pragmatic systematic reviews had a higher average scores across all domains, with lower scores in the primary analysis domain.

The difference in the main analysis domain could be due to the fact that most pragmatic trials analyse their data in an intention to treat way, whereas some explanatory trials do not. The overall score for 프라그마틱 무료 슬롯 플레이; https://gpsites.stream/, pragmatic systematic reviews was lower when the domains of management, flexible delivery and follow-up were merged.

It is important to note that a pragmatic trial doesn't necessarily mean a low-quality trial, and there is an increasing rate of clinical trials (as defined by MEDLINE search, but it is neither specific nor sensitive) that use the term 'pragmatic' in their title or abstract. The use of these terms in abstracts and titles could indicate a greater understanding of the importance of pragmatism, however, it is not clear if this is manifested in the contents of the articles.

Conclusions

As appreciation for the value of evidence from the real world becomes more widespread, pragmatic trials have gained popularity in research. They are clinical trials randomized that evaluate real-world alternatives to care rather than experimental treatments under development. They have patients that more closely mirror those treated in routine care, they use comparators which exist in routine practice (e.g. existing drugs), and they depend on participants' self-reports of outcomes. This approach has the potential to overcome the limitations of observational research, such as the limitations of relying on volunteers and limited availability and 프라그마틱 데모 coding variability in national registry systems.

Other advantages of pragmatic trials include the ability to utilize existing data sources, and a greater probability of detecting significant changes than traditional trials. However, they may be prone to limitations that compromise their credibility and generalizability. For 프라그마틱 슬롯무료 example the participation rates in certain trials might be lower than expected due to the healthy-volunteer effect as well as financial incentives or competition for participants from other research studies (e.g. industry trials). The need to recruit individuals in a timely manner also restricts the sample size and the impact of many pragmatic trials. Certain pragmatic trials lack controls to ensure that observed differences aren't caused by biases in the trial.

The authors of the Pragmatic Free Trial Meta identified 48 RCTs that self-described themselves as pragmatic and were published up to 2022. They assessed pragmatism using the PRECIS-2 tool, which consists of the domains eligibility criteria and recruitment criteria, as well as flexibility in adherence to intervention, and follow-up. They discovered that 14 of these trials scored as highly or pragmatic sensible (i.e. scoring 5 or more) in one or more of these domains and that the majority of them were single-center.

Trials with high pragmatism scores are likely to have more criteria for eligibility than traditional RCTs. They also include populations from many different hospitals. The authors argue that these characteristics could make the pragmatic trials more relevant and applicable to daily practice, but they do not guarantee that a pragmatic trial is free of bias. Moreover, the pragmatism of the trial is not a definite characteristic and a pragmatic trial that does not possess all the characteristics of an explanatory trial can produce valid and useful results.